Pharma and life sciences
Furnished apartments and houses near European pharma sites, arranged for commissioning and validation teams staying three to eighteen months, on one contract and one invoice.
The short version
Your peak headcount does not arrive with the civils. It arrives when the building is weather-tight and the commissioning, qualification and validation programme starts: FAT and SAT witnessing, utilities handover, IQ, OQ, PQ, cleanroom classification. On a bulk biological API project, validation alone accounts for 10–15% of total installed cost, and qualification costs "at least twice as much as that of commissioning" (ISPE Pharmaceutical Engineering). That is the phase where you need 10 to 80 specialists living within a sensible drive of the gate, for three to eighteen months, without churn.
Churn is the specific thing to avoid. ISPE's own guidance is that "for true integration to take place and in order for commissioning to be leveraged into qualification, it is strongly advised to have the same team members perform qualification for the systems they commissioned" (ISPE Pharmaceutical Engineering). If a validation engineer loses their apartment at month five because a summer let expired, you are not losing a bed — you are losing system knowledge from a protocol execution sequence that is already on the critical path.
Bonjour Residences is an independent agency. We do not own units. We source them from a vetted partner network — including local owners who never list online — and we stand behind the booking, the invoice and the support for the length of the stay.
The demand curve
A pharma capital project produces three distinct accommodation demands, and most suppliers only understand the first.
Phase one, civils and structure. Large, mostly regional trades, high turnover, usually housed by the main contractor. Kalundborg is the scale marker: Novo Nordisk committed "more than 42 billion Danish kroner starting in 2023", with construction projects "finalised gradually from the end of 2025 through 2029" and "up to 3,000 external employees" employed during the construction phase (Novo Nordisk).
Phase two, mechanical completion into CQV. Headcount profile inverts. Fewer people, far more specialist, much longer individual stays, and they are travelling internationally by design. A commissioning and qualification field-service role advertised in Ireland lists "extensive travel across Ireland, UK, Europe and occasional international assignments" and states plainly that "candidates must be willing to stay away from home for extended periods when required" (Cpl). The recruitment market prices this as a mobile contract discipline: commissioning engineers from £45,000 up to validation leads and CQV managers at £75,000+ across the UK, Ireland and Europe (QCS Staffing), with an average Irish life-sciences contractor day rate of €513 in 2026 (HERO Recruitment). Biologics makes it heavier again: across an ISPE benchmark of 50 projects, "the average IQOQ cost as a percentage of TIC was twice as large" for biological facilities as for other facility types (ISPE Pharmaceutical Engineering, Jan/Feb 2007).
Phase three, and this is the part that changes the buying decision — requalification. Under EU GMP Annex 1, "the maximum time interval for requalification of grade A & B areas, is 6 months" and "the maximum time interval for requalification of grade C & D areas, is 12 months" (§4.32), and heat sterilisation cycles "should be revalidated with a minimum frequency of at least annually for load patterns that are considered worst case" (§8.39) (European Commission, EU GMP Annex 1). Cleanrooms are qualified in accordance with Annex 15, in operation since 1 October 2015 and now under revision (EMA concept paper); verify the current text before relying on it commercially. In practice, the team that qualified the facility comes back on a cycle. A sterile site is not a one-off booking, it is a returning campaign — and we plan it that way.
We should also be straight about the direction of travel. Lilly will "halve its originally planned investment of €2.3 billion" in Germany (Reuters, 3 June 2026) and Novo Nordisk plans to "eliminate approximately 5,000 positions in its home country" (Reuters, 25 September 2025). That is why this page is built on commissioning pipelines already in the ground, not on announcement volume.
In the ground now
| Project | Location | Sponsor | Scale | Published construction / commissioning workforce |
|---|---|---|---|---|
| API and packaging expansion | Kalundborg, Denmark | Novo Nordisk | >DKK 42bn; 170,000 m² API facility; completing 2025–2029 | Up to 3,000 external employees (Novo Nordisk) |
| Aseptic and finished-product expansion | Chartres, France | Novo Nordisk | >DKK 16bn (€2.1bn); finalising 2026–2028; NNP3 lines "en cours de validation" as of May 2026 | Up to 2,000 external employees; more than 900 people mobilised daily on the aseptic building (Novo Nordisk · Novo Nordisk France) |
| Injectable manufacturing site | Alzey, Germany | Eli Lilly | $2.5bn as announced, operational from 2027; investment since halved with over a billion euros already invested | An estimated 1,900 jobs during construction (Lilly) |
| Single-use biologics facility | Dundalk, Ireland | WuXi Biologics | €325m, 48,000 m² | Peak of 2,000 workers on site (Irish Examiner) |
| Oral GLP-1 tabletting facility | Athlone, Ireland | Novo Nordisk | €432m, completing late 2027 through 2028 | Up to 500 construction jobs (Novo Nordisk release) |
| New aseptic site, three cleanrooms | Saarlouis, Germany | Vetter | ~€480m first phase, 50,000 m²; construction from Q2 2026, commissioning planned 2031 | Not published (Vetter) |
| Biologics expansion, 8 × 20,000L | Hillerød, Denmark | Fujifilm Biotechnologies | USD 1.6bn (DKK 11bn), completion expected summer 2026 | Not published (Fujifilm) |
| Insulin plant replacement | Frankfurt, Germany | Sanofi | €1.3bn, 36,000 m², replacing the Hoechst plant by 2029 | Not published (Reuters) |
| Mammalian and HPAPI expansion | Visp, Switzerland | Lonza | ~CHF 650m mammalian facility; HPAPI facility expected operational 2028 | Not published (Lonza, 2021 · Lonza, 2026) |
| Site redevelopment and R&D | Basel, Switzerland | Roche | CHF 1.2bn, buildings completing by 2030 | Not published (Roche) |
Swipe the table sideways to see every column.
Where a sponsor has not published a headcount, we say so rather than estimate it.
Local supply
Kalundborg, Denmark. The site employs "around 5,500 individuals in a town of 16,500" (Reuters), and approximately 10,000 people work at the factory as employees or contractors (CNN, 7 May 2026). Reuters records "the strain on the housing market as homeowners convert their residences into accommodations for construction personnel", and a student describing house-hunting there: "in some ways, you are competing with Novo when searching for a place to live". Local agents put new supply "three to five years behind demand" (Ekstra Bladet). Homelessness in the municipality rose from 19 people in 2017 to 89 in 2024, an increase of almost 400% (DR). Relief is coming slowly: over 1,000 homes are under construction per the mayor (CNN), the largest new residential zone permits up to about 638 homes with the first 136 being built, and the Copenhagen motorway is expected in 2028 (Kalundborg Kommune).
Visp, Switzerland. Just over 8,000 people live in Visp and Lonza counts 4,500 employees, with a further 1,500 people employed temporarily (SRF · SRF). The advertised-vacancy rate stood at 1.8% against 5.8% nationally, rents rose 3.7% in a year, and the roughly 400 new flats under construction were "erst in ein bis zwei Jahren bezugsbereit" — a one-to-two-year wait (SRF). Temporary Lonza staff are already living in surrounding villages: around 40 to 45 of them in Ausserberg alone (Blick).
Athlone, Ireland. Athlone was one of 12 study areas nationwide with no properties available within HAP limits for any household category — the second consecutive report showing zero — with 21 properties available to rent per day on average and median rents of €1,300 for one-bed and €1,500 for two-bed homes (Westmeath Independent). The town is now a designated rent pressure zone (Athlone Advertiser).
Ravensburg, Germany. Vetter's home district was short around 2,800 homes at the end of 2020 and reports that building has largely come to a standstill, with financing costs three to four times higher than two years earlier (Landkreis Ravensburg); asking rents hit €12.18/m² in Q2 2026 (ImmoScout24).
And the people you are housing are increasingly not local. International staff in Danish consulting-engineering firms rose from 244 (2.0%) in 2020 to 1,448 (9.4%) in 2024, with international employees at 13% of Danish medicinal-industry employment (FRI Indsigt 2/2026). Ireland forecasts 21,000 additional biopharma jobs by 2027 against average annual recruitment of more than 5,600, and names commissioning engineers as a priority skill need (Government of Ireland / EGFSN · EGFSN, Skills for Biopharma).
How we work
We block accommodation for the CQV window, not for a calendar month, because ISPE advises keeping the same people through commissioning into qualification (ISPE). Extensions get handled inside the existing arrangement wherever the partner allows it, so a slipped OQ does not put an engineer back on the open market.
Media fills, sterilisation cycles and cleanroom clean-up testing do not respect office hours; Annex 1 requires qualification in both "at rest" and "in operation" states (European Commission). We prioritise self-catering units with a real kitchen, laundry and parking, and we split teams across properties so night-shift and day-shift people are not sharing a wall.
Headcount on a CQV programme typically changes twice before mobilisation and again at handover. We hold the flexibility in the block of properties rather than in the contract, coordinate staggered check-ins, and keep a WhatsApp channel open for the team during the stay.
Most validation specialists travel to site and go home periodically — the market is explicit that extended time away from home is part of the role (Cpl). We favour locations that work for a Friday airport or rail run, and hold rooms across rotation gaps where the arrangement allows.
Process
Send the requirement. Site postcode, team size, dates, budget. A gate address and a headcount is enough to start.
Get tailored options. Sourced from partners in that market, including owners who do not list online.
Confirm once. We handle booking coordination, contracts and staggered check-ins with every owner.
We hold the line. One channel for your team, one invoice for finance, for the length of the stay.
For finance and procurement
One consolidated VAT-compliant invoice covering every property and every country on the project, in your local currency where we can — which matters when validation sits inside a capitalised project cost that has to be allocated cleanly by work package.
Corporate contracts run on 30-day payment terms. No personal cards exposed and no individual receipts for engineers to submit against a per-diem policy while they are executing protocols.
One onboarding, one set of compliance documents, one contact — instead of a new vendor in every country your posted-worker paperwork already has to cover. See pricing for how rates are built.
Coverage
Coverage runs to 27 European markets plus project work in the United States. See the full locations list, the contractor accommodation hub, or the sector pages for data centre construction, semiconductor fabs and energy and infrastructure.
Questions
Both, but the commissioning and validation phase is where we do most of our pharma work. Those stays are longer, the same people need to be retained through qualification, and the local market is usually already full by the time CQV starts.
Yes, and it is one of the hardest markets in Europe: around 10,000 people work at the site as employees or contractors in a town of fewer than 17,000, and homeowners have been converting houses into accommodation for construction personnel (CNN · Reuters). We source through local partners rather than public listings, including surrounding towns where that is the honest answer.
Teams of 1 to 200+, handled as one coordinated booking. Pharma commissioning requirements usually land between 10 and 80 people for three to eighteen months.
We treat extensions as the normal case. Where a partner can extend, we extend inside the existing arrangement; where they cannot, we re-source before the end date rather than at it. We do not publish response-time guarantees — we tell you what is actually available in that market.
No. Bonjour Residences is an independent agency. We source from a vetted network of over 3,000 property partners, including local owners who do not list online, and we stand behind the booking, the invoice and the support.
Because qualification is periodic. EU GMP Annex 1 sets a maximum requalification interval of 6 months for grade A and B areas and 12 months for grade C and D (European Commission). Sterile sites bring specialist teams back on a cycle, so we plan repeat requirements rather than one-off bookings.
Yes. Units are self-catering with a kitchen and laundry, and we split teams across properties so that night-shift commissioning staff are not housed alongside day-shift colleagues.
One consolidated VAT-compliant invoice covering every property and country, on 30-day corporate terms, with one supplier record and one set of compliance documents.
Site location, team size, dates, budget. If you are between mechanical completion and IQ, that is exactly the point to talk to us.
